
Medibest Pharma Private Limited
Pharmaceutical company manufacturing and exporting various medications and supplements.
Pharmaceutical company manufacturing and exporting various medications and supplements.
Medibest Pharma Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 July 1985 and has a history of 39 years and eight months. Its registered office is in Krishnagiri, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 2.76 Cr.
The company currently has active open charges totaling ₹12.14 Cr. The company has closed loans amounting to ₹5.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shanthi Sankar, Puthukode Vigneshwar, and Puthucode Venkateswaran serve as directors at the Company.
Krishnagiri, Tamil Nadu, India
+91-XXXXXXXXXX
U24231TZ1985PTC003995
003995
Private Limited Indian Non-Government Company
31 Jul 1985
30 Sep 2024
31 Mar 2024
Unlisted
Roc Coimbatore
Medibest Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Antihistamines, Mineral Supplement, Sexual Wellness Products, Contraceptives, Anti Infective Drugs & Medicines, Anti Allergic Drug, Respiratory System Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Puthucode Venkateswaran ![]() | Managing Director | 31-Jul-1985 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shanthi Sankar ![]() | Director | 24-Nov-2016 | Current |
Puthukode Vigneshwar ![]() | Director | 23-Mar-2017 | Current |
Medibest Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 64.94% increase. The company also saw a substantial improvement in profitability, with a 1857.09% increase in profit. The company's net worth Soared by an impressive increase of 24.6%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Medibest Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
₹12.14 Cr
₹5.97 Cr
Date | Lender | Amount | Status |
---|---|---|---|
27 Dec 2024 | Sidbi | ₹1.85 Cr | Open |
30 Sep 2022 | City Union Bank Limited | ₹10.22 Cr | Open |
14 Jul 2021 | Hdfc Bank Limited | ₹0.71 M | Open |
09 Jul 2008 | Tamilnadu Industrial Investment Corporation Limited | ₹3.52 Cr | Satisfied |
13 Jan 1999 | The Tamil Nadu Industrial Investment Corpn. Ltd. | ₹1.11 M | Satisfied |
Unlock and access historical data on people associated with Medibest Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medibest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medibest Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Sidbi amounted to Rs. 1.85 Cr with Charge ID 101030567 was registered on 27 Dec 2024.
Medibest Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with City Union Bank Limited of Rs. 10.22 Cr registered on 30 Sep 2022 with Charge ID 100620608 was modified on 03 Jun 2024.
Medibest Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore.
A charge with City Union Bank Limited amounted to Rs. 10.22 Cr with Charge ID 100620608 was registered on 30 Sep 2022.
A charge registered on 14 Jul 1987 via Charge ID 90007789 with Others was fully satisfied on 29 Sep 2022.
Medibest Pharma Private Limited was incorporated on 31 Jul 1985.
The authorized share capital of Medibest Pharma Private Limited is ₹ 3.60 Cr and paid-up capital is ₹ 2.76 Cr.
Currently 3 directors are associated with Medibest Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medibest Pharma Private Limited is No 31Sidco Industrial Estate India, Hosur, Tamil Nadu, 635126.
The corporate identification number (CIN) of Medibest Pharma Private Limited is U24231TZ1985PTC003995 and the company number is 003995 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2024, the revenue trend for Medibest Pharma Private Limited has risen by 64.94%.
The financial reports for the fiscal year 2024 indicates that The net worth of Medibest Pharma Private Limited has experienced an upsurge of 24.60%.
As per the financial statements for fiscal Year 2024, The total open charges for Medibest Pharma Private Limited amount to ₹ 12.14 Cr.
The most recent Balance Sheet for Medibest Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
KK
PR
PK